ERG and prostate cancer: A recent study revealed ERG-specific metabolic alterations, particularly connected to fatty acid oxidation [17] and an earlier study found increased glucose uptake to be related to the metabolic sensor neuropeptide gamma (NPY) in ERG rearrangement positive prostate cancer [18].